Intravenous immunoglobulins may prevent prednisone-exacerbation in myasthenia gravis
Abstract Corticosteroids may produce a paradoxical worsening of myasthenia gravis (MG) symptoms within the first weeks of treatment. We therefore wanted to assess the hypothesis that a prior infusion of intravenous immunoglobulin (IVIG) may have a protective effect. Our primary objectives were to sh...
Guardado en:
Autores principales: | Laura Díez-Porras, Christian Homedes, Maria Antonia Alberti, Valentina Vélez-Santamaría, Carlos Casasnovas |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/242967baf4764d01abfbcf9b81b6a5e2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Profound olfactory dysfunction in myasthenia gravis.
por: Fidias E Leon-Sarmiento, et al.
Publicado: (2012) -
Fetal Surveillance in Pregnancies with Myasthenia Gravis
por: Brîndușa Ana Cimpoca-Raptis, et al.
Publicado: (2021) -
PLASMAPHERESIS IN THE TREATMENT OF MYASTHENIA GRAVIS: OUTCOME AND COMPLICATIONS
por: Maryam Abbas, et al.
Publicado: (2021) -
Frontalis sling procedure for ocular myasthenia gravis
por: Isogai N, et al.
Publicado: (2012) -
Current and emerging therapies for the treatment of myasthenia gravis
por: Renato Mantegazza, et al.
Publicado: (2011)